Monoclonal Antibody to Von Hippel Lindau Tumor Suppressor (vHL) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.
RPJ769Ra01-Recombinant Von Hippel Lindau Tumor Suppressor (vHL)
Recommended Usage
Western blotting: 0.2-2µg/mL;1:500-5000 Immunohistochemistry: 5-20µg/mL;1:50-200 Immunocytochemistry: 5-20µg/mL;1:50-200 Optimal working dilutions must be determined by end user.
